NCT06597721
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06597721
Title AMT-754 in Patients With Selected Advanced Solid Tumours
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Multitude Therapeutics Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | AUS

Facility Status City State Zip Country Details
Highlands Oncology Group RECRUITING Rogers Arkansas 72758 United States Details
Yale University Cancer Center RECRUITING New Haven Connecticut 06520 United States Details
Massachusetts General Hospital RECRUITING Boston Massachusetts 02114 United States Details
MD Anderson Cancer Center RECRUITING Houston Texas 77030 United States Details
START San Antonio RECRUITING San Antonio Texas 78229 United States Details
Scientia Clinical Research RECRUITING Randwick New South Wales 2031 Australia Details
Southern Oncology Clinical Research Unit RECRUITING Bedford Park South Australia 5042 Australia Details
Peninsula and South Eastern Haematology and Oncology Group (PSEHOG) RECRUITING Frankston Victoria 3199 Australia Details
Cabrini Hospital RECRUITING Malvern Victoria 3144 Australia Details
Linear Clinical Research RECRUITING Nedlands Western Australia 6009 Australia Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field